YSP jumps 8.3% on better 2Q earnings, dividend payout
Page 1 of 1
YSP jumps 8.3% on better 2Q earnings, dividend payout
YSP jumps 8.3% on better 2Q earnings, dividend payout
KUALA LUMPUR (Aug 20): Shares in generic drugs maker YSP Southeast Asia Holdings Bhd (YSP) ([You must be registered and logged in to see this image.] Financial Dashboard) surged as much as 21 sen or 8.3% after the group posted better earnings in the second quarter ended June 30, 2015 (2QFY15).
At 2.40pm, the stock pared some gains and was trading at RM2.70, still up 18 sen or 7.14%, making it the sixth-largest gainer across the stock exchange.
Some 769,700 shares were traded between RM2.37 and RM2.73 today. The current price gives it a market capitalisation of RM365.81 million.
The counter has been on an uptrend since Monday (Aug 17), when it was trading at RM2.26, having gained 20.8% in just a week, outperforming the benchmark FBM KLCI's 0.05% increase in the same period.
YSP (fundamental: 2.5; valuation: 2) had announced on Tuesday that its net profit for the 2QFY15 ballooned to RM3.42 million from a mere RM964,000 in the same period last year, due to higher revenue and lower cost margin for product mix sold.
Revenue for the quarter also went up 9.8% to RM50.63 million from RM46.11 million in 2QFY14.
The group also declared a 6.5 sen dividend on the release of the latest quarterly results, payable on Aug 25.
For the six-month period, its net profit almost doubled to RM12.77 million against RM6.41 million last year, while revenue strengthen 12.7% to RM109.94 million from RM97.54 million.
Going forward, YSP said its prospects for domestic and overseas manufacturing plant, consumer healthcare products and traditional complementary medicine remained good in the markets it operates.
"Efforts in introducing more new range of products will be stepped up to broaden our market base," it had said.
However, it also noted that uncertainties in the global economic outlook and the weakening of the ringgit were some factors that may impact its earnings.
(Note: The Edge Research's fundamental score reflects a company's profitability and balance sheet strength, calculated based on historical numbers. The valuation score determines if a stock is attractively valued or not, also based on historical numbers. A score of 3 suggests strong fundamentals and attractive valuations.)
KUALA LUMPUR (Aug 20): Shares in generic drugs maker YSP Southeast Asia Holdings Bhd (YSP) ([You must be registered and logged in to see this image.] Financial Dashboard) surged as much as 21 sen or 8.3% after the group posted better earnings in the second quarter ended June 30, 2015 (2QFY15).
At 2.40pm, the stock pared some gains and was trading at RM2.70, still up 18 sen or 7.14%, making it the sixth-largest gainer across the stock exchange.
Some 769,700 shares were traded between RM2.37 and RM2.73 today. The current price gives it a market capitalisation of RM365.81 million.
The counter has been on an uptrend since Monday (Aug 17), when it was trading at RM2.26, having gained 20.8% in just a week, outperforming the benchmark FBM KLCI's 0.05% increase in the same period.
YSP (fundamental: 2.5; valuation: 2) had announced on Tuesday that its net profit for the 2QFY15 ballooned to RM3.42 million from a mere RM964,000 in the same period last year, due to higher revenue and lower cost margin for product mix sold.
Revenue for the quarter also went up 9.8% to RM50.63 million from RM46.11 million in 2QFY14.
The group also declared a 6.5 sen dividend on the release of the latest quarterly results, payable on Aug 25.
For the six-month period, its net profit almost doubled to RM12.77 million against RM6.41 million last year, while revenue strengthen 12.7% to RM109.94 million from RM97.54 million.
Going forward, YSP said its prospects for domestic and overseas manufacturing plant, consumer healthcare products and traditional complementary medicine remained good in the markets it operates.
"Efforts in introducing more new range of products will be stepped up to broaden our market base," it had said.
However, it also noted that uncertainties in the global economic outlook and the weakening of the ringgit were some factors that may impact its earnings.
(Note: The Edge Research's fundamental score reflects a company's profitability and balance sheet strength, calculated based on historical numbers. The valuation score determines if a stock is attractively valued or not, also based on historical numbers. A score of 3 suggests strong fundamentals and attractive valuations.)
Cals- Administrator
- Posts : 25277 Credits : 57721 Reputation : 1766
Join date : 2011-09-08
Location : global
Comments : “My plan of trading was sound enough and won oftener that it lost. If I had stuck to it Iâ€d have been right perhaps as often as seven out of ten times.â€
Stock Exposure : Technical Analysis / Fundamental Analysis / Mental Analysis
Similar topics
» Highlight GBH jumps 9.8% on dividend payout
» Hot Stock George Kent jumps 3.05% on stronger 3Q earnings, dividend
» Update EPF declares 6.35% dividend for 2013, record dividend payout of RM31.2 billion
» BIMB proposes 8.5% dividend payout
» Petronas lowers dividend payout for 2013
» Hot Stock George Kent jumps 3.05% on stronger 3Q earnings, dividend
» Update EPF declares 6.35% dividend for 2013, record dividend payout of RM31.2 billion
» BIMB proposes 8.5% dividend payout
» Petronas lowers dividend payout for 2013
Page 1 of 1
Permissions in this forum:
You cannot reply to topics in this forum